Trial Profile
A retrospective study of cetuximab plus irinotecan in patients with colorectal cancer prior treated with a fluoropyrimidine, oxaliplatin and irinotecan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology